| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.31% |
| NAV | ₹11.95 (22 Oct 2020) |
|---|---|
| Fund Started | 27 Jul 2018 |
| Fund Size | ₹172 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Infosys Ltd. | Technology | Equity | 6.6% |
| HDFC Bank Ltd. | Financial | Equity | 5.8% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 5.1% |
| Hindustan Unilever Ltd. | FMCG | Equity | 4.7% |
| Reliance Industries Ltd. | Energy | Equity | 4.6% |
| Lupin Ltd. | Healthcare | Equity | 3.7% |
| Dabur India Ltd. | FMCG | Equity | 3.6% |
| Avenue Supermarts Ltd. | Services | Equity | 3.6% |
| Laurus Labs Ltd. | Healthcare | Equity | 3.4% |
| Dhanuka Agritech Ltd. | Chemicals | Equity | 3.0% |
IDFC Equity Opportunity Series 6 Regular Growth is a Equity Mutual Fund Scheme launched by IDFC Mutual Fund. This scheme was made available to investors on 27 Jul 2018. Anoop Bhaskar, Sumit Agrawal, Kartik Mehta is the Current Fund Manager of IDFC Equity Opportunity Series 6 Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹172 Cr and the Latest NAV as of 22 Oct 2020 is ₹11.95.
The IDFC Equity Opportunity Series 6 Regular Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The Scheme seeks to generate capital appreciation from a portfolio that is invested in equity and equity related securities of Indian and foreign companies.